• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于Lasso特征筛选的慢性阻塞性肺疾病患者列线图预测模型的建立

Establishment of nomogram prediction model for patients with chronic obstructive pulmonary disease based on Lasso feature screening.

作者信息

Zhang Shuyi, Sha Jiaojiao, Jiang Tao, Lu Zhou, Shi Yulin, Xu Jiatuo

机构信息

School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Sichuan College of Traditional Chinese Medicine, Sichuan Province, China.

出版信息

Digit Health. 2025 May 29;11:20552076251346674. doi: 10.1177/20552076251346674. eCollection 2025 Jan-Dec.

DOI:10.1177/20552076251346674
PMID:40453046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12123110/
Abstract

BACKGROUND AND OBJECTIVE

To establish a nomogram prediction model for patients with chronic obstructive pulmonary disease (COPD) based on Lasso feature screening using acoustic features and general clinical data, as well as a risk warning model for patients with acute exacerbation of COPD (AECOPD), and to investigate the performance and value of these two models.

METHODS

A total of 240 male COPD patients, including 41 patients with acute exacerbation, and 82 healthy control male volunteers were enrolled as subjects from October 2022 to January 2024. Acoustic features and general clinical data were collected. Lasso regression was used to screen variables related to COPD and AECOPD diagnosis, and nomogram models were separately established and verified by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve.

RESULTS

Variables related to COPD diagnosis screened by Lasso regression included age, smoking history, a_Jitter, e_MFCC1, e_F2 frequency, i_H1-A3, i_F1 amplitude, o_F1 amplitude, and u_MFCC4, and the variables related to AECOPD included expectoration, mMRC grade, i_Jitter, i_F2 frequency, i_Alpha Ratio, and u_H1-H2. The ROC Curve showed that the Area Under the Curve (AUC) of the COPD nomogram model was 0.95, and the AUC of the AECOPD risk warning model was 0.83. The calibration curve indicated that nomogram models showed reasonable consistency, and the Mean Absolute Error (MAE) values were 0.026 and 0.028, respectively. The decision curve indicated that nomogram models showed good benefit, and the benefit thresholds were nearly full threshold, and 0.11-81 and 0.88-0.99, respectively.

CONCLUSION

The nomogram models for COPD prediction and risk warning of AECOPD can be used as a clinical auxiliary diagnostic and early screening method, providing new insights into the intelligent auscultation of COPD.

摘要

背景与目的

基于Lasso特征筛选,利用声学特征和一般临床数据,建立慢性阻塞性肺疾病(COPD)患者的列线图预测模型以及慢性阻塞性肺疾病急性加重(AECOPD)患者的风险预警模型,并探究这两种模型的性能和价值。

方法

2022年10月至2024年1月,共纳入240例男性COPD患者(其中41例为急性加重患者)以及82名健康男性志愿者作为研究对象。收集声学特征和一般临床数据。采用Lasso回归筛选与COPD及AECOPD诊断相关的变量,并分别建立列线图模型,通过受试者工作特征(ROC)曲线、校准曲线和决策曲线进行验证。

结果

经Lasso回归筛选出的与COPD诊断相关的变量包括年龄、吸烟史、a_Jitter、e_MFCC1、e_F2频率、i_H1 - A3、i_F1幅度、o_F1幅度和u_MFCC4,与AECOPD相关的变量包括咳痰、mMRC分级、i_Jitter、i_F2频率、i_Alpha Ratio和u_H1 - H2。ROC曲线显示,COPD列线图模型的曲线下面积(AUC)为0.95,AECOPD风险预警模型的AUC为0.83。校准曲线表明列线图模型具有合理的一致性,平均绝对误差(MAE)值分别为0.026和0.028。决策曲线表明列线图模型具有良好的效益,效益阈值分别接近全阈值以及0.11 - 81和0.88 - 0.99。

结论

COPD预测和AECOPD风险预警的列线图模型可作为临床辅助诊断和早期筛查方法,为COPD的智能听诊提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/d6998421950a/10.1177_20552076251346674-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/0ad2e87272f2/10.1177_20552076251346674-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/b8af16bdd3ae/10.1177_20552076251346674-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/0af690fbd9df/10.1177_20552076251346674-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/60c15e6afc6b/10.1177_20552076251346674-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/3a66ac2147d3/10.1177_20552076251346674-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/a4fa4ec774a9/10.1177_20552076251346674-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/b89ace8a839e/10.1177_20552076251346674-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/930cc756c24c/10.1177_20552076251346674-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/491d96f65b07/10.1177_20552076251346674-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/69b9b146b6f2/10.1177_20552076251346674-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/57dc86677e05/10.1177_20552076251346674-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/d6998421950a/10.1177_20552076251346674-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/0ad2e87272f2/10.1177_20552076251346674-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/b8af16bdd3ae/10.1177_20552076251346674-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/0af690fbd9df/10.1177_20552076251346674-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/60c15e6afc6b/10.1177_20552076251346674-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/3a66ac2147d3/10.1177_20552076251346674-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/a4fa4ec774a9/10.1177_20552076251346674-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/b89ace8a839e/10.1177_20552076251346674-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/930cc756c24c/10.1177_20552076251346674-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/491d96f65b07/10.1177_20552076251346674-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/69b9b146b6f2/10.1177_20552076251346674-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/57dc86677e05/10.1177_20552076251346674-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/12123110/d6998421950a/10.1177_20552076251346674-fig12.jpg

相似文献

1
Establishment of nomogram prediction model for patients with chronic obstructive pulmonary disease based on Lasso feature screening.基于Lasso特征筛选的慢性阻塞性肺疾病患者列线图预测模型的建立
Digit Health. 2025 May 29;11:20552076251346674. doi: 10.1177/20552076251346674. eCollection 2025 Jan-Dec.
2
Construction and validation of nomogram prediction model for risk of acute heart failure in patients with acute exacerbation of chronic obstructive pulmonary disease.构建和验证预测慢性阻塞性肺疾病急性加重患者发生急性心力衰竭风险的列线图预测模型。
Medicine (Baltimore). 2024 Jan 5;103(1):e36840. doi: 10.1097/MD.0000000000036840.
3
[Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].基于回归分析的慢性阻塞性肺疾病急性加重风险预测模型的建立与验证
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jan;33(1):64-68. doi: 10.3760/cma.j.cn121430-20200720-00534.
4
A Diagnostic Nomogram for Predicting Hypercapnic Respiratory Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.用于预测慢性阻塞性肺疾病急性加重患者高碳酸血症性呼吸衰竭的诊断列线图。
Int J Chron Obstruct Pulmon Dis. 2024 May 18;19:1079-1091. doi: 10.2147/COPD.S454558. eCollection 2024.
5
Analysis of risk factors and development of predictive model for acute myocardial injury in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者急性心肌损伤的危险因素分析及预测模型的建立
J Thorac Dis. 2025 Apr 30;17(4):1977-1990. doi: 10.21037/jtd-2024-1992. Epub 2025 Apr 27.
6
Construction and validation of risk prediction model for deep vein thrombosis in acute exacerbations of chronic obstructive pulmonary disease based on serum angiopoietin 2 levels.基于血清血管生成素 2 水平的慢性阻塞性肺疾病急性加重期深静脉血栓形成风险预测模型的构建与验证。
Ann Palliat Med. 2021 Jul;10(7):7905-7918. doi: 10.21037/apm-21-1448.
7
Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients.开发和验证用于评估慢性阻塞性肺疾病急性加重患者生存情况的列线图。
BMC Pulm Med. 2024 Jun 19;24(1):287. doi: 10.1186/s12890-024-03091-w.
8
[Establishment and effect evaluation of nomogram model for diagnosis and prediction of pulmonary hypertension in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺动脉高压诊断与预测列线图模型的建立及效果评价]
Zhonghua Yi Xue Za Zhi. 2022 Oct 18;102(38):3019-3025. doi: 10.3760/cma.j.cn112137-20220512-01045.
9
Development and Validation of an In-Hospital Mortality Prediction Model for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重患者住院死亡率预测模型的建立与验证。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 12;19:1303-1314. doi: 10.2147/COPD.S461269. eCollection 2024.
10
Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease.入院时血液标志物评估对慢性阻塞性肺疾病社区获得性肺炎的预测作用。
COPD. 2021 Oct;18(5):557-566. doi: 10.1080/15412555.2021.1976739. Epub 2021 Sep 12.

本文引用的文献

1
Gender impact on pancreatic neuroendocrine neoplasm (PanNEN) prognosis according to survival nomograms.根据生存列线图分析性别对胰腺神经内分泌肿瘤(PanNEN)预后的影响。
Endocrine. 2025 Apr;88(1):14-23. doi: 10.1007/s12020-024-04129-z. Epub 2024 Dec 13.
2
COPDVD: Automated classification of chronic obstructive pulmonary disease on a new collected and evaluated voice dataset.COPDVD:在新收集和评估的语音数据集上对慢性阻塞性肺疾病进行自动化分类。
Artif Intell Med. 2024 Oct;156:102953. doi: 10.1016/j.artmed.2024.102953. Epub 2024 Aug 15.
3
Development and validation of an early diagnosis model for bone metastasis in non-small cell lung cancer based on serological characteristics of the bone metastasis mechanism.
基于骨转移机制血清学特征的非小细胞肺癌骨转移早期诊断模型的建立与验证
EClinicalMedicine. 2024 Apr 26;72:102617. doi: 10.1016/j.eclinm.2024.102617. eCollection 2024 Jun.
4
Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors.雷切尔评分:用于预测肺神经内分泌肿瘤预后的列线图模型。
J Endocrinol Invest. 2024 Oct;47(10):2575-2586. doi: 10.1007/s40618-024-02346-x. Epub 2024 Mar 23.
5
Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease.左心疾病所致肺动脉高压的诊断列线图的建立与验证。
Heart Lung. 2024 May-Jun;65:11-18. doi: 10.1016/j.hrtlng.2024.01.005. Epub 2024 Feb 16.
6
Acoustic-Based Deep Learning Architectures for Lung Disease Diagnosis: A Comprehensive Overview.基于声学的深度学习架构在肺病诊断中的应用:全面综述
Diagnostics (Basel). 2023 May 16;13(10):1748. doi: 10.3390/diagnostics13101748.
7
[Current methods of acoustic analysis of voice: a review].[当前嗓音声学分析方法综述]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec;36(12):966-970;976. doi: 10.13201/j.issn.2096-7993.2022.12.016.
8
[Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021)].慢性阻塞性肺疾病诊断和管理指南(2021年修订版)
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031.
9
The diagnosis of respiratory disease in children using a phone-based cough and symptom analysis algorithm: The smartphone recordings of cough sounds 2 (SMARTCOUGH-C 2) trial design.基于电话的咳嗽和症状分析算法诊断儿童呼吸疾病:智能手机记录咳嗽声音 2(SMARTCOUGH-C 2)试验设计。
Contemp Clin Trials. 2021 Feb;101:106278. doi: 10.1016/j.cct.2021.106278. Epub 2021 Jan 12.
10
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.